Integrating pathogenic mechanisms in Parkinson's disease
Integrating pathogenic mechanisms in Parkinson's disease
批准号:
10198049
负责人:
RAYMOND A SWANSON
金额:
$33.53万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-15 至 2023-05-31
关键词:
ABL1 geneAffectBindingCatecholaminesCell Culture TechniquesCell RespirationCellsChronicCysteineDNA DamageDNA Sequence AlterationEnvironmental Risk FactorEnzymesEstersEtiologyEvaluationGap JunctionsGeneticGlutathioneGlutathione DisulfideHumanImpairmentInflammationInflammatoryKnowledgeLeadLinkMetalsMitochondriaModelingMonitorMouse StrainsMusNADPH OxidaseNeuronsOralOxidation-ReductionOxidative StressOxidesParkinson DiseasePathogenesisPathogenicityPathologyPathway interactionsPeroxidesPharmacologyProcessProductionProtein Tyrosine KinaseProteinsQuality ControlReactive Oxygen SpeciesSulfhydryl CompoundsSuperoxidesTestingTherapeuticTissuesToxinTransgenic MiceTransition Elementsalpha synucleindisease phenotypeexcitatory amino acid transporter 3in vivomitochondrial dysfunctionmouse modelmulticatalytic endopeptidase complexneuron lossnovelnovel therapeuticsoverexpressionoxidant stressoxidationoxidative damagerepairedresponsetool
中文摘要
摘要
α-突触核蛋白表达、c-Abl激活和神经元谷胱甘肽水平分别为
被认为是帕金森病的促成因素,但这些因素如何相互作用,
不太了解。这种知识差距具有基本和治疗意义,因为
这些相互作用可能定义了帕金森病的最终共同途径
发病机制谷氨酸被神经元用来抑制活性氧
并修复氧化损伤的蛋白质。在帕金森病中,α-
突触核蛋白寡聚体与谷胱甘肽耗竭、氧化应激和神经元损伤有关。
死亡α-突触核蛋白聚集体的形成由c-Abl促进,c-Abl是一种酪氨酸激酶,
由氧化应激激活。我们假设α-突触核蛋白聚集体驱动
通过金属催化过程形成活性氧,
由此产生的谷胱甘肽耗竭有助于α-突触核蛋白聚集和c-Abl活化,
前馈方式。我们将使用细胞培养模型来检验这一假设,其中α-
突触核蛋白聚集体、硫醇氧化还原状态和c-Abl活性可以独立地操纵
并受到监控。我们还将采用两种新的双转基因小鼠品系,
α-突触核蛋白聚集及其相关病理学的评价(1)
NADPH氧化酶活性缺乏,和(2)神经元谷胱甘肽水平降低。这些
菌株,结合新的药理学工具,将使我们能够确定原因-
神经元氧化应激、α-突触核蛋白聚集和c-Abl之间的效应关系
体内活性。
1
英文摘要
ABSTRACT
α-synuclein expression, c-Abl activation, and neuronal glutathione levels are each
recognized as contributory factors in Parkinson’s disease, but how these factors interact is
poorly understood. This knowledge gap is of basic and therapeutic relevance because
these interactions may define a final common pathway in Parkinson’s disease
pathogenesis. Glutathione is used by neurons to both scavenge reactive oxygen species
and repair oxidatively damage proteins. In Parkinson’s disease, the accumulation of α-
synuclein oligomers is associated with glutathione depletion, oxidative stress, and neuronal
death. α-synuclein aggregate formation is promoted by c-Abl, a tyrosine kinase that is in
turn activated by oxidative stress. We hypothesize that α-synuclein aggregates drive
reactive oxygen species formation through metal-catalyzed processes, and that the
resulting glutathione depletion contributes to α-synuclein aggregation and c-Abl activation in
a feed-forward manner. We will test this hypothesis using cell culture models in which α-
synuclein aggregates, thiol redox state, and c-Abl activity can be independently manipulated
and monitored. We will also employ two novel double-transgenic mouse strains that permit
evaluation of a-synuclein aggregation and its associated pathology in the setting of (1)
deficient NADPH oxidase activity, and (2) reduced neuronal glutathione levels. These
strains, in combination with novel pharmacological tools, will allow us to identify cause-
effect relationships between neuronal oxidative stress, α-synuclein aggregation, and c-Abl
activity in vivo.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diversity Supplement to R01NS105774
-
批准号:10350351
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2021
-
负责人:RAYMOND A SWANSON
-
依托单位:
Ischemia-induced injury to neuronal processes: role of cofilin-actin rod formation
-
批准号:10477194
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:RAYMOND A SWANSON
-
依托单位:
Ischemia-induced injury to neuronal processes: role of cofilin-actin rod formation
-
批准号:10664943
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:RAYMOND A SWANSON
-
依托单位:
Integrating pathogenic mechanisms in Parkinson's disease
-
批准号:10430048
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2018
-
负责人:RAYMOND A SWANSON
-
依托单位:
Integrating pathogenic mechanisms in Parkinson's disease
-
批准号:10682994
-
项目类别:
-
资助金额:$7.86万
-
财政年份:2018
-
负责人:RAYMOND A SWANSON
-
依托单位:
Regulatory Control of Glutamate - Induced Superoxide Production
-
批准号:8539111
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2012
-
负责人:RAYMOND A SWANSON
-
依托单位:
Regulatory Control of Glutamate - Induced Superoxide Production
-
批准号:8421981
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2012
-
负责人:RAYMOND A SWANSON
-
依托单位:
Regulatory Control of Glutamate - Induced Superoxide Production [Admin Supplement]
-
批准号:8992559
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:RAYMOND A SWANSON
-
依托单位:
Regulatory Control of Glutamate - Induced Superoxide Production
-
批准号:8658868
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2012
-
负责人:RAYMOND A SWANSON
-
依托单位:
Regulatory Control of Glutamate - Induced Superoxide Production
-
批准号:8851695
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2012
-
负责人:RAYMOND A SWANSON
-
依托单位:
Three-day scientific conference to be held April 18-20, 2012
-
批准号:8256406
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2011
-
负责人:RAYMOND A SWANSON
-
依托单位:
Effects of PARP-1 gene deletion in a mouse model of Alzheimer's disease
-
批准号:7314167
-
项目类别:
-
资助金额:$19.65万
-
财政年份:2007
-
负责人:RAYMOND A SWANSON
-
依托单位:
Effects of PARP-1 gene deletion in a mouse model of Alzheimer's disease
-
批准号:7477642
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2007
-
负责人:RAYMOND A SWANSON
-
依托单位:
VIIth International Conference on Brain Energy Metabolism
-
批准号:7163659
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2006
-
负责人:RAYMOND A SWANSON
-
依托单位:
Hypoglycemic neuronal death
-
批准号:6952732
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2004
-
负责人:RAYMOND A SWANSON
-
依托单位:
Hypoglycemic neuronal death
-
批准号:7459598
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2004
-
负责人:RAYMOND A SWANSON
-
依托单位:
Hypoglycemic neuronal death
-
批准号:7095857
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2004
-
负责人:RAYMOND A SWANSON
-
依托单位:
Hypoglycemic neuronal death
-
批准号:6861494
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2004
-
负责人:RAYMOND A SWANSON
-
依托单位:
Hypoglycemic neuronal death
-
批准号:7291620
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2004
-
负责人:RAYMOND A SWANSON
-
依托单位:
PARP induced oxidative stress and mitochondrial failure
-
批准号:6664640
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2002
-
负责人:RAYMOND A SWANSON
-
依托单位:
海外基金